about
Portrait of ependymoma recurrence in children: biomarkers of tumor progression identified by dual-color microarray-based gene expression analysisCraniopharyngiomaReduced H3K27me3 and DNA hypomethylation are major drivers of gene expression in K27M mutant pediatric high-grade gliomasRecurrent activating ACVR1 mutations in diffuse intrinsic pontine gliomaFunctionally defined therapeutic targets in diffuse intrinsic pontine gliomaPediatric craniopharyngiomas: classification and treatment according to the degree of hypothalamic involvement.Chordoma in children: Case-report and review of literature.Reprint of "Chordoma in children: Case-report and review of literature"Impairment of intellectual functions after surgery and posterior fossa irradiation in children with ependymoma is related to age and neurologic complicationsRadiotherapy with concurrent and adjuvant temozolomide in children with newly diagnosed diffuse intrinsic pontine glioma.Phase II study of irinotecan in combination with temozolomide (TEMIRI) in children with recurrent or refractory medulloblastoma: a joint ITCC and SIOPE brain tumor studyEvaluation of a novel antibody to define histone 3.3 G34R mutant brain tumours.Pediatric low-grade gliomas: how modern biology reshapes the clinical field.Mesenchymal transition and PDGFRA amplification/mutation are key distinct oncogenic events in pediatric diffuse intrinsic pontine gliomas.Long time to diagnosis of medulloblastoma in children is not associated with decreased survival or with worse neurological outcomep53 Pathway dysfunction in primary childhood ependymomas.MYB-QKI rearrangements in angiocentric glioma drive tumorigenicity through a tripartite mechanism.New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs.Neuronal differentiation distinguishes supratentorial and infratentorial childhood ependymomasHistopathological grading of pediatric ependymoma: reproducibility and clinical relevance in European trial cohorts.Childhood ependymoma: a systematic review of treatment options and strategies.Mortality in Children with Optic Pathway Glioma Treated with Up-Front BB-SFOP Chemotherapy.Prognostic classification of pediatric medulloblastoma based on chromosome 17p loss, expression of MYCC and MYCN, and Wnt pathway activation.Measuring the neuro-cognitive side-effects of irradiation in children with brain tumors.Craniopharyngioma: the pendulum of surgical management.The therapy of infantile malignant brain tumors: current status?Expression profiles of 151 pediatric low-grade gliomas reveal molecular differences associated with location and histological subtype.Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypesPseudoprogression after high-dose busulfan-thiotepa with autologous stem cell transplantation and radiation therapy in children with brain tumors: Impact on survival.Papillary glioneuronal tumors: histological and molecular characteristics and diagnostic value of SLC44A1-PRKCA fusion.Bevacizumab dosing strategy in paediatric cancer patients based on population pharmacokinetic analysis with external validation.Multimodal treatment of craniopharyngioma: defining a risk-adapted strategy.Recent development in chemotherapy of paediatric brain tumours.Pediatric infratentorial gangliogliomas: a retrospective series.Re-irradiation of recurrent pediatric ependymoma: modalities and outcomes: a twenty-year survey.Medulloblastoma: what is the role of molecular genetics?Forniceal glioma in children. Clinical article.Medulloblastoma in young children.Paediatric and adult glioblastoma: multiform (epi)genomic culprits emerge.Development of the SIOPE DIPG network, registry and imaging repository: a collaborative effort to optimize research into a rare and lethal disease
P50
Q21136141-45F97CEC-C845-4E04-B02F-D23E0AB7B38EQ21203013-77D0B4F7-CA60-443F-8FBC-ACD9D3CF1608Q24339074-E7DAE8C3-1523-4865-B84C-63D770A47356Q28237518-6BF24049-9248-4870-B56E-EEEE556141FEQ28833173-DA9148DB-87F5-4C0E-91AC-ABE3CCBA9545Q31093878-61C0484A-D149-469D-8854-91F06DDECB12Q33275928-4837A4E8-9527-4EEE-BC47-BEA6E4C02767Q33276114-2459C14D-B1A9-40AE-A27B-1C9C2FB58731Q33315598-6C0A17AB-EEA7-4658-B45D-0EBCB864372EQ33396801-B8743AB1-C907-438F-84DC-43F99F270250Q33409117-CAF1418A-CFB8-442C-8D37-0B5740AE34EEQ33771688-65DDD02E-DC26-47A2-B09E-2E89050ED97FQ33847771-DC6687D6-AA3B-4A47-A7C0-1DBF89CDA30DQ34184430-3E912512-CE03-4060-9EFC-D3BBC503A6E1Q34224760-03622EC5-B06B-4E5D-9D30-A459583CDFF8Q34441161-E608D48C-46F9-4048-B08A-A044F0D2AE4AQ34511655-EDA33F29-A163-46C3-9767-F88C48801C49Q34515911-E200AFB0-B9FB-4890-B127-917DF31A9BEBQ34992547-CF8DE25D-AE2C-41FE-B838-0B11C6125A85Q35053098-2A7AC56D-B628-4618-93F5-5C7C4D8FB8CFQ35190610-3CA53C5B-1580-40A6-BAE6-CBEAEAECA88AQ35670831-CFC8E664-D801-480A-9AA4-4184003B85FFQ35696363-7D314289-4401-409E-96C1-3BC61BE2F213Q35719629-150E7A4E-EC06-40D9-8E43-AD759A1D3339Q36217560-803FE98C-A005-4D2B-9B35-674D59987275Q36272998-27797BFF-BBA2-41D4-817A-617B0459B772Q36288263-8A2E4980-871D-4A50-82AF-DEEF109DDEBEQ36303824-B703415C-53E6-4F2D-9200-0D5E9E56F748Q36344743-373EB0C6-5681-4E7E-987E-41980CBB4F13Q36376520-F20EA09E-BCA4-4CCB-8B97-F8245A536E0CQ36410210-B66D972F-94FC-4EA5-9166-DA730B978604Q36478532-4721B1F4-A770-4A8F-BEB0-1AC0467E1AD3Q36956114-9C67254D-7B35-480F-8B1E-059C4A95A939Q36973698-53EC5E6F-2317-4570-A633-AE030ED76CE2Q37037444-EE79E309-3576-4714-BE3D-F96EC0A623F5Q37202789-E49147C4-D45D-4DA5-86AB-966CE89A99FCQ37601489-4C2F0BF7-8144-45CE-BFEF-30AC57EF72A0Q37690235-D5325655-674D-4FB7-A0A3-746EDA1DC7CDQ37729676-BAD81511-C454-44F6-A648-1B770A16B24EQ37736041-531A1ADA-EFE7-4AF6-B12A-5DB94A0AC867
P50
description
researcher ORCID ID = 0000-0003-4773-3001
@en
wetenschapper
@nl
name
Jacques Grill
@ast
Jacques Grill
@en
Jacques Grill
@es
Jacques Grill
@nl
type
label
Jacques Grill
@ast
Jacques Grill
@en
Jacques Grill
@es
Jacques Grill
@nl
prefLabel
Jacques Grill
@ast
Jacques Grill
@en
Jacques Grill
@es
Jacques Grill
@nl
P214
38146094225700331353
P31
P496
0000-0003-4773-3001
P735
P7859
viaf-38146094225700331353